相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hepatitis C Virus Infection of Neuroepithelioma Cell Lines
Nicola F. Fletcher et al.
GASTROENTEROLOGY (2010)
Role of Scavenger Receptor Class B Type I in Hepatitis C Virus Entry: Kinetics and Molecular Determinants
Maria Teresa Catanese et al.
JOURNAL OF VIROLOGY (2010)
Splicing Diversity of the Human OCLN Gene and Its Biological Significance for Hepatitis C Virus Entry
Indu Kohaar et al.
JOURNAL OF VIROLOGY (2010)
The Disulfide Bonds in Glycoprotein E2 of Hepatitis C Virus Reveal the Tertiary Organization of the Molecule
Thomas Krey et al.
PLOS PATHOGENS (2010)
Review article: investigational agents for chronic hepatitis C
A. J. V. Thompson et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Increased HDL Cholesterol and ApoA-I in Humans and Mice Treated With a Novel SR-BI Inhibitor
David Masson et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Modeling HCV kinetics under therapy using PK and PD information
Emi Shudo et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2009)
Hepatitis C virus entry: molecular mechanisms and targets for antiviral therapy
Mirjam B. Zeisel et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Visualizing Hepatitis C Virus Infections in Human Liver by Two-Photon Microscopy
Yuqiong Liang et al.
GASTROENTEROLOGY (2009)
Amphipathic DNA Polymers Inhibit Hepatitis C Virus Infection by Blocking Viral Entry
Takuya Matsumura et al.
GASTROENTEROLOGY (2009)
Tight Junction Proteins Claudin-1 and Occludin Control Hepatitis C Virus Entry and Are Downregulated during Infection To Prevent Superinfection
Shufeng Liu et al.
JOURNAL OF VIROLOGY (2009)
The Tight Junction-Associated Protein Occludin Is Required for a Postbinding Step in Hepatitis C Virus Entry and Infection
Ignacio Benedicto et al.
JOURNAL OF VIROLOGY (2009)
Human occludin is a hepatitis C virus entry factor required for infection of mouse cells
Alexander Ploss et al.
NATURE (2009)
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Dongliang Ge et al.
NATURE (2009)
Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection
John G. McHutchison et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor
David M. Owen et al.
VIROLOGY (2009)
RNA Interference and Single Particle Tracking Analysis of Hepatitis C Virus Endocytosis
Kelly E. Coller et al.
PLOS PATHOGENS (2009)
Receptor Complementation and Mutagenesis Reveal SR-BI as an Essential HCV Entry Factor and Functionally Imply Its Intra- and Extra-Cellular Domains
Marlene Dreux et al.
PLOS PATHOGENS (2009)
Anti-CD81 Antibodies Can Prevent a Hepatitis C Virus Infection In Vivo
Philip Meuleman et al.
HEPATOLOGY (2008)
Identification of a Residue in Hepatitis C Virus E2 Glycoprotein That Determines Scavenger Receptor BI and CD81 Receptor Dependency and Sensitivity to Neutralizing Antibodies
Joe Grove et al.
JOURNAL OF VIROLOGY (2008)
CD81 and claudin 1 coreceptor association: Role in hepatitis C virus entry
Helen J. Harris et al.
JOURNAL OF VIROLOGY (2008)
The impact of disease recurrence on graft survival following liver transplantation: a single centre experience
Ian A. Rowe et al.
TRANSPLANT INTERNATIONAL (2008)
The way forward in HCV treatment - finding the right path (vol 6, pg 991, 2007)
Michael P. Manns et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion
Pablo Gastaminza et al.
JOURNAL OF VIROLOGY (2008)
Hepatitis C virus receptor expression in normal and diseased liver tissue
Gary M. Reynolds et al.
HEPATOLOGY (2008)
The way forward in HCV treatment - finding the right path (vol 6, pg 991, 2007)
Michael P. Manns et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge
Mansun Law et al.
NATURE MEDICINE (2008)
The way forward in HCV treatment - finding the right path
Michael P. Manns et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
CD81 expression is important for the permissiveness of Huh7 cell clones for heterogeneous hepatitis C virus infection
Daisuke Akazawa et al.
JOURNAL OF VIROLOGY (2007)
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry
Matthew J. Evans et al.
NATURE (2007)
The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus
Sonia Molina et al.
JOURNAL OF HEPATOLOGY (2007)
Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo
Thomas Von Hahn et al.
GASTROENTEROLOGY (2007)
The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells
George Koutsoudakis et al.
JOURNAL OF VIROLOGY (2007)
Hepatitis C virus entry requires a critical postinternalization step and delivery to early endosomes via clathrin-coated vesicles
Laurent Meertens et al.
JOURNAL OF VIROLOGY (2006)
Viral and cellular determinants of the hepatitis C virus envelope-heparan sulfate interaction
Heidi Barth et al.
JOURNAL OF VIROLOGY (2006)
Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope protein glycans
Francois Helle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
High-density lipoproteins reduce the neutralizing effect of hepatitis C virus (HCV)-infected patient antibodies by promoting HCV entry
Cecile Voisset et al.
JOURNAL OF GENERAL VIROLOGY (2006)
Arbidol:: a broad-spectrum antiviral that inhibits acute and chronic HCV infection
Yury S. Boriskin et al.
VIROLOGY JOURNAL (2006)
Hepatitis C virus entry depends on clathrin-mediated endocytosis
Emmanuelle Blanchard et al.
JOURNAL OF VIROLOGY (2006)
Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses
George Koutsoudakis et al.
JOURNAL OF VIROLOGY (2006)
Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients
SU Nielsen et al.
JOURNAL OF VIROLOGY (2006)
Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry
DM Tscherne et al.
JOURNAL OF VIROLOGY (2006)
Adaptive immune responses in acute and chronic hepatitis C virus infection
DG Bowen et al.
NATURE (2005)
Unravelling hepatitis C virus replication from genome to function
BD Lindenbach et al.
NATURE (2005)
Complete replication of hepatitis C virus in cell culture
BD Lindenbach et al.
SCIENCE (2005)
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome
T Wakita et al.
NATURE MEDICINE (2005)
An interplay between hypervariable region 1 of the Hepatitis C Virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies
B Bartosch et al.
JOURNAL OF VIROLOGY (2005)
Robust hepatitis C virus infection in vitro
J Zhong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Folding and dimerization of hepatitis C virus E1 and E2 glycoproteins in stably transfected CHO cells
M Brazzoli et al.
VIROLOGY (2005)
The tetraspanin web modulates immune-signalling complexes
S Levy et al.
NATURE REVIEWS IMMUNOLOGY (2005)
CD81 is required for hepatitis C virus glycoprotein-mediated viral infection
J Zhang et al.
JOURNAL OF VIROLOGY (2004)
L-SIGN (CD209L) and DC-SIGN (0209) mediate transinfection of liver cells by hepatitis C virus
EG Cormier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner
JA McKeating et al.
JOURNAL OF VIROLOGY (2004)
CD81 is an entry coreceptor for hepatitis C virus
EG Cormier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor
B Bartosch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles
M Hsu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues
A Rigotti et al.
ENDOCRINE REVIEWS (2003)
Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes
B Bartosch et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Highly active antiretroviral therapy-induced lipodystrophy has minor effects on human immunodeficiency virus-induced changes in lipolysis, but normalizes resting energy expenditure
M van der Valk et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus
E Scarselli et al.
EMBO JOURNAL (2002)
Characterization of low- and very-low-density hepatitis C virus RNA-containing particles
P André et al.
JOURNAL OF VIROLOGY (2002)
Surprisingly small effect of antiviral treatment in patients with hepatitis C
Y Falck-Ytter et al.
ANNALS OF INTERNAL MEDICINE (2002)
Construction and characterization of chimeric hepatitis C virus E2 glycoproteins: analysis of regions critical for glycoprotein aggregation and CD81 binding
AH Patel et al.
JOURNAL OF GENERAL VIROLOGY (2000)
Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees
X Forns et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Charged residues in the transmembrane domains of hepatitis C virus glycoproteins play a major role in the processing, subcellular localization, and assembly of these envelope proteins
L Cocquerel et al.
JOURNAL OF VIROLOGY (2000)
分享论文
